BioNTech SE Statistics

Total Valuation

BioNTech SE has a market cap or net worth of $25.81 billion. The enterprise value is $9.99 billion.

Market Cap	25.81B
Enterprise Value	9.99B

Important Dates

The next confirmed earnings date is Tuesday, May 5, 2026, before market open.

Earnings Date	May 5, 2026
Ex-Dividend Date	n/a

Share Statistics

BioNTech SE has 252.88 million shares outstanding. The number of shares has increased by 0.54% in one year.

Current Share Class	n/a
Shares Outstanding	252.88M
Shares Change (YoY)	+0.54%
Shares Change (QoQ)	+2.02%
Owned by Insiders (%)	16.73%
Owned by Institutions (%)	20.46%
Float	109.30M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.66
Forward PS	11.31
PB Ratio	1.14
P/TBV Ratio	1.27
P/FCF Ratio	78.41
P/OCF Ratio	48.21
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.96
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	30.35

Financial Position

The company has a current ratio of 7.54, with a Debt / Equity ratio of 0.01.

Current Ratio	7.54
Quick Ratio	6.87
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	0.95
Interest Coverage	-89.20

Financial Efficiency

Return on equity (ROE) is -5.88% and return on invested capital (ROIC) is -25.47%.

Return on Equity (ROE)	-5.88%
Return on Assets (ROA)	-3.56%
Return on Invested Capital (ROIC)	-25.47%
Return on Capital Employed (ROCE)	-6.38%
Weighted Average Cost of Capital (WACC)	12.91%
Revenue Per Employee	$431,614
Profits Per Employee	-$170,862
Employee Count	7,807
Asset Turnover	0.13
Inventory Turnover	3.10

Taxes

In the past 12 months, BioNTech SE has paid $100.15 million in taxes.

Income Tax	100.15M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +0.04% in the last 52 weeks. The beta is 1.59, so BioNTech SE's price volatility has been higher than the market average.

Beta (5Y)	1.59
52-Week Price Change	+0.04%
50-Day Moving Average	98.11
200-Day Moving Average	102.77
Relative Strength Index (RSI)	54.96
Average Volume (20 Days)	878,929

Short Selling Information

The latest short interest is 3.22 million, so 4.70% of the outstanding shares have been sold short.

Short Interest	3.22M
Short Previous Month	3.51M
Short % of Shares Out	4.70%
Short % of Float	n/a
Short Ratio (days to cover)	3.48

Income Statement

In the last 12 months, BioNTech SE had revenue of $3.37 billion and -$1.33 billion in losses. Loss per share was -$5.52.

Revenue	3.37B
Gross Profit	2.65B
Operating Income	-1.49B
Pretax Income	-1.23B
Net Income	-1.33B
EBITDA	-1.32B
EBIT	-1.49B
Loss Per Share	-$5.52

Full Income Statement

Balance Sheet

The company has $16.13 billion in cash and $313.96 million in debt, giving a net cash position of $15.82 billion or $62.56 per share.

Cash & Cash Equivalents	16.13B
Total Debt	313.96M
Net Cash	15.82B
Net Cash Per Share	$62.56
Equity (Book Value)	22.57B
Book Value Per Share	89.81
Working Capital	16.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $535.40 million and capital expenditures -$205.59 million, giving a free cash flow of $329.15 million.

Operating Cash Flow	535.40M
Capital Expenditures	-205.59M
Depreciation & Amortization	167.09M
Net Borrowing	-59.64M
Free Cash Flow	329.15M
FCF Per Share	$1.30

Full Cash Flow Statement

Margins

Gross margin is 78.70%, with operating and profit margins of -44.14% and -39.59%.

Gross Margin	78.70%
Operating Margin	-44.14%
Pretax Margin	-36.61%
Profit Margin	-39.59%
EBITDA Margin	-39.17%
EBIT Margin	-44.14%
FCF Margin	9.77%

Dividends & Yields

BioNTech SE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.54%
Shareholder Yield	-0.54%
Earnings Yield	-5.17%
FCF Yield	1.28%

Dividend Details

Analyst Forecast

The average price target for BioNTech SE is $133.46, which is 30.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$133.46
Price Target Difference	30.77%
Analyst Consensus	Strong Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	7.98%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioNTech SE has an Altman Z-Score of 6.72 and a Piotroski F-Score of 4.

Altman Z-Score	6.72
Piotroski F-Score	4